Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Study Looks At Efficacy, Cardiovascular Risks Of Two HIV Treatments
Patients taking Boehringer Ingelheim"s HIV drug Viramune have a lower risk of developing cardiovascular disease than those taking Bristol-Myers Squibb"s treatment, Reyataz, according to a study released on Monday at the 5th International AIDS Society conference in Cape Town, South Africa, Reuters reports. "The drug trial, involving 569 participants, yielded that Viramune, while being as effective at suppressing HIV as Bristol Myers" blockbuster Reyataz, had a more favourable effect on patients" cardiovascular risks, as measured by certain blood lipids," the article states. The study found that "Viramune-treated patients ò€¦ had more than twice the level of HDL cholesterol, known as "good cholesterol" for its benefitial effect on blood vessels, than those on Reyataz, Boehringer said in a statement," Reuters reports. The article adds that advances in antiretroviral drugs have helped make HIV a "treatable chronic condition," and "as a result, patients are growing older, bringing other symptoms of an HIV infection, such as cardiovascular diseases, to the fore" (Burger, Reuters, 7/20).

MGH Study Identifies First Molecular Steps To Childhood Leukemia
A Massachusetts General Hospital (MGH)-based research team has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL)- the most common cancer in children- initiates the disease process. In the July issue of Cell Stem Cell, they describe how expression of this mutation in hematopoietic stem cells (HSCs), which usually occurs before birth, leads to the development of leukemia many years later.
News of the day
Blanket Support For Trauma Victims Not Best Way To Prevent PTSD
Say a deadly campus shooting occurs. It might seem sensible to offer everyone on campus psychological support to prevent psychological repercussions, including posttraumatic stress disorder (PTSD).
Mental Health

Healthcare Advocates To Protest Secretary Sebelius Visit

HHS Secretary Proclaims: "Single-Payer is Not Part of the Discussion" Allows Health Insurance Corporations to Continue Patient Abuses What Nurses, patients, doctors, and other healthcare advocates will protest Secretary of Health and Human Services Kathleen Sebelius" visit to San Francisco. The health advocates will protest Secretary Sebelius" recent assertion that "single-payer is not part of the discussion." This statement reflects the desire by Washington politicians to keep their insurance donors at the heart of the healthcare industry-despite their long record of patient abuse. When Monday - June 22nd, 11 a.m. Where Fairmont Hotel - 950 Mason St., San Francisco Why "Secretary Sebelius seems quite proud that Washington politicians are barring and discussion or consideration of the single-payer systems flourishing in other countries. Nurses, however, are dismayed because we know this is really a recipe for more waste, fraud, profit-taking, and abuse committed by health insurance corporations against the patients we see every day. We will never be able to provide comprehensive or quality care as long as we"re also subsidizing insurance industry overhead," said Geri Jenkins, RN, co-president of the National Nurse Organizing Committee/California Nurses Association. California Nurses Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009